logo

[breadcrumb_custom]

VBI Vaccines Inc. (VBIV) Stock: A Comprehensive 52-Week Review

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. VBI Vaccines Inc.’s current trading price is -92.66% away from its 52-week high, while its distance from the 52-week low is 55.56%. The stock’s price range during this period has varied between $0.45 and $9.54. The company, active in the Healthcare sector, saw a trading volume of around 3.86 million for the day, considerably higher average daily volume of 0.12 million observed over the last three months.

The market performance of VBI Vaccines Inc. has been somewhat unstable. Over the past year, the company’s stock achieved a high of $9.54 on 04/03/23, with the lowest value for the same timeframe being $0.45, recorded on 10/25/23.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

How Financial Performance Impacts Market Capitalization

VBI Vaccines Inc. (VBIV) has experienced a quarterly rise of 19.15% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 16.58M.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.6161, with a change in price of +0.0999. Similarly, VBI Vaccines Inc. recorded 165,606 in trading volume during the last 100 days, posting a change of +16.65%.

How VBIV’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for VBIV stands at 2.65. Similarly, the long-term debt-to-equity ratio is also 0.07.

VBIV Stock Stochastic Average

As of today, the raw stochastic average of VBI Vaccines Inc. over the last 50 days is at 74.30%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 83.33%. Further, the company’s Stochastic %K and %D values for the last 20 days were 73.33% and 62.65%, respectively.

VBIV Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a gain of 19.15%.However, over the last six months, we can see a weaker performance of 5.07%. Over the last 30 days, the price of VBIV has fallen by 18.64%. And in the last five days, it has surged by 21.76%.

On Key

Related Posts